Sodium transport through the cerebral sodium–glucose transporter exacerbates neuron damage during cerebral ischaemia

Journal of Pharmacy and Pharmacology

Volumn , Issue , 2016, Pages 922-931

  Yamazaki, Yui ^a   Harada, Shinichi ^a   Wada, Tetsuyuki ^b   Yoshida, Shigeru ^b   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KINKI UNIVERSITY   (Japan)

Author keywords

cerebral ischaemia; hyperglycaemia; sodium influx; sodium glucose transporter; methyl d glucopyranoside

Indexed keywords

METHYLGLUCOSIDE; PHLORIZIN; SODIUM GLUCOSE COTRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; FETUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NONHUMAN; SODIUM TRANSPORT; SURVIVAL RATE; WESTERN BLOTTING;

EID: 84975229499     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12571     Document Type: Article

References (49)

1. Gao H-J et al. Ligustrazine monomer against cerebral ischemia/reperfusion injury. Neural Regen Res 2015; 10: 832–840.
2. Sarwar N et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215–2222.
3. Ogbera AO et al. Glucose and lipid assessment in patients with acute stroke. Int Arch Med 2014; 7: 45.
4. Harada S et al. The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage. Brain Res 2009; 1279: 174–181.
5. Harada S et al. The importance of regulation of blood glucose levels through activation of peripheral 5'-AMP-activated protein kinase on ischemic neuronal damage. Brain Res 2010; 1351: 254–263.
6. Yamazaki Y et al. Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia. Neurosci Lett 2015; 604: 134–139.
7. Yamazaki Y et al. Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter. Brain Res 2012; 1489: 113–120.
8. Harada S et al. Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia. Brain Res 2013; 1541: 61–68.
9. Wright EM. Renal Na+-glucose cotransporters. Am J Physiol Ren Physiol 2001; 280: 10–18.
10. Gonzàlez JA et al. Dissociation between sensing and metabolism of glucose in sugar sensing neurones. J Physiol 2009; 587: 41–48.
11. Scheepers A et al. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function. JPEN J Parenter Enteral Nutr 2004; 28: 364–371.
12. Wright EM, Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch 2004; 447: 510–518.
13. Dreier JP. The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 2011; 17: 439–447.
14. 2+ signals and neuronal death in brain ischemia. Stroke 2007; 38: 674–676.
15. McDonald JW et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 1998; 4: 291–297.
16. Morikawa E et al. Attenuation of focal ischemic brain injury in mice deficient in the epsilon1 (NR2A) subunit of NMDA receptor. J Neurosci 1998; 18: 9727–9732.
17. Fujita-Hamabe W, Tokuyama S. The involvement of cleavage of neural cell adhesion molecule in neuronal death under oxidative stress conditions in cultured cortical neurons. Biol Pharm Bull 2012; 35: 624–628.
18. Yamazaki Y et al. Sodium-glucose transporter type 3-mediated neuroprotective effect of acetylcholine suppresses the development of cerebral ischemic neuronal damage. Neuroscience 2014; 269: 134–142.
19. Harada S et al. Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage. J Pharmacol Sci 2011; 115: 155–163.
20. Haley TJ, Mccormick WG. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 1957; 12: 12–15.
21. Capes SE et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001; 32: 2426–2432.
22. Gentile NT et al. Decreased mortality by normalizing blood glucose after acute ischemic stroke. Acad Emerg Med 2006; 13: 174–180.
23. Harada S et al. Orexin-A suppresses postischemic glucose intolerance and neuronal damage through hypothalamic brain-derived neurotrophic factor. J Pharmacol Exp Ther 2013; 344: 276–285.
24. Wright EM et al. Biology of human sodium glucose transporters. Physiol Rev 2011; 91: 733–794.
25. Yamazaki Y et al. Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia. Neuroscience 2015; 310: 674–685.
26. O'Malley D et al. Sodium-coupled glucose cotransporters contribute to hypothalamic glucose sensing. Diabetes 2006; 55: 3381–3386.
27. 2+ overload and calpain activation in neurons. Oxid Med Cell Longev 2013; 2013: 367206.
28. Nicholls DG. Mitochondrial calcium function and dysfunction in the central nervous system. Biochim Biophys Acta 2009; 1787: 1416–1424.
29. Xie Y et al. Prolonged deficits in parvalbumin neuron stimulation-evoked network activity despite recovery of dendritic structure and excitability in the somatosensory cortex following global ischemia in mice. J Neurosci 2014; 34: 14890–14900.
30. Murphy TH et al. Two-photon imaging of stroke onset in vivo reveals that NMDA-receptor independent ischemic depolarization is the major cause of rapid reversible damage to dendrites and spines. J Neurosci 2008; 28: 1756–1772.
31. Drenckhahn C et al. A validation study of the use of near-infrared spectroscopy imaging in primary and secondary motor areas of the human brain. Epilepsy Behav 2015; 49: 118–125.
32. Enger R et al. Dynamics of ionic shifts in cortical spreading depression. Cereb Cortex 2015; 25:4469–4476 doi: 10.1093/cercor/bhv054.
33. Oláh G et al. Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeability. Drug Des Devel Ther 2013; 7: 981–987.
34. Maslarova A et al. Chronically epileptic human and rat neocortex display a similar resistance against spreading depolarization in vitro. Stroke 2011; 42: 2917–2922.
35. Takeda Y et al. Metabolic and perfusion responses to recurrent peri-infarct depolarization during focal ischemia in the Spontaneously Hypertensive Rat: dominant contribution of sporadic CBF decrements to infarct expansion. J Cereb Blood Flow Metab 2011; 31: 1863–1873.
36. Pivovarova NB et al. The interactive roles of zinc and calcium in mitochondrial dysfunction and neurodegeneration. J Neurochem 2014; 128: 592–602.
37. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 2001; 81: 1065–1096.
38. Strong AJ et al. Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex. Brain 2007; 130: 995–1008.
39. Soria FN et al. Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage. J Clin Invest 2014; 124: 3645–3655.
40. Cuomo O et al. Ionic homeostasis in brain conditioning. Front Neurosci 2015; 9: 277.
41. Gribble FM et al. A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 2003; 52: 1147–1154.
42. Eskandari S et al. Kinetics of the reverse mode of the Na+/glucose cotransporter. J Membr Biol 2005; 204: 23–32.
43. Dirnagl U et al. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391–397.
44. Shahveisi K et al. The role of local renin-angiotensin system on high glucose-induced cell toxicity, apoptosis and reactive oxygen species production in PC12 cells. Iran J Basic Med Sci 2014; 17: 613–621.
45. Shao B, Bayraktutan U. Hyperglycaemia promotes human brain microvascular endothelial cell apoptosis via induction of protein kinase C-ßI and prooxidant enzyme NADPH oxidase. Redox Biol 2014; 2: 694–701.
46. Lu X et al. Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction. Oncol Lett 2014; 7: 1992–1996.
47. Zhang W et al. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J (Engl) 2009; 122: 1996–2001.
48. Fung C et al. Hypoxic-ischemic brain injury exacerbates neuronal apoptosis and precipitates spontaneous seizures in glucose transporter isoform 3 heterozygous null mice. J Neurosci Res 2010; 88: 3386–3398.
49. Espinoza-Rojo M et al. Glucose transporters regulation on ischemic brain: possible role as therapeutic target. Cent Nerv Syst Agents Med Chem 2010; 10: 317–325.